The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells

BACKGROUND: Rhabdoid tumors are highly aggressive malignancies affecting infants and very young children. In many instances these tumors are resistant to conventional type chemotherapy necessitating alternative approaches. METHODS: Proliferation assays (MTT), apoptosis (propidium iodide/annexin V) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerl, Kornelius, Ries, David, Unland, Rebecca, Borchert, Christiane, Moreno, Natalia, Hasselblatt, Martin, Jürgens, Heribert, Kool, Marcel, Görlich, Dennis, Eveslage, Maria, Jung, Manfred, Meisterernst, Michael, Frühwald, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693872/
https://www.ncbi.nlm.nih.gov/pubmed/23764045
http://dx.doi.org/10.1186/1471-2407-13-286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693872/
https://www.ncbi.nlm.nih.gov/pubmed/23764045
http://dx.doi.org/10.1186/1471-2407-13-286

Ejemplares similares